DO YOU KNOW SOMEONE TROUBLED BY CANCER?
In 2015,- 90.5 million worldwide diagnosed with cancers.
By 2019,- 123.6 million are ill – 10 million dead worldwide.
BUT IT DOESN’T HAVE TO BE LIKE THIS
If you, or others you know, are afflicted with such tumours, DON’T DESPAIR, there is a new and better way to successfully treat’ most of them,
Your present ‘government’ condoned the Medicines & Healthcare Products Regulatory Agency’s [MH(P)RA] action in destroying a very successful UK product and telling patients that chemo- and radio-therapy is the best treatment possible.
Actually if the victim AVOIDS the chemo- and radio-therapy option, there is a product, known as Gc-MAF, which will successfully ‘treat’ 89% of all cases, even up to Stage 4.
Although some people have actually been imprisoned for talking about it, now, the world knows that there IS a product available, and that it works!
Get online and go to https://gcmafplus.com/ for help (people using the ‘under the tongue’ spray report the best results) in getting this successful cancer treatment.
For a deeper understanding of what lies behind such headline claims, you can search our main BLOG area: – enter the word CANCER – and see how ten years of hard work and research were ruthlessly crushed, how individuals were imprisoned, both here in England, and also within the European Union territory, for daring to speak the truth. You may wish to ask yourself what charges could possibly be brought against well-intentioned, talented professionals?
It apparently boils down to semantics, claiming a ‘cure’ when, as long ago as 1939, by a statute known as ‘The Cancer Act’, it had been decided that the highest claim permitted would be to discuss a ‘treatment’ – just NEVER to utter the word – CURE.
We seek neither profit nor praise for telling the truth: however, the Medicines and Healthcare Products Regulatory Agency [MH(P)RA] generates enormous profits from promoting the chemo- and radio-therapy route as the preferred course of ‘treatment’.
There is another way forward. You decide.